计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| T111224-25g |
25g |
现货 ![]() |
| |
| T111224-100g |
100g |
现货 ![]() |
| |
| T111224-500g |
500g |
现货 ![]() |
|
| 别名 | 乙酸茶碱,茶碱-7-乙酸 |
|---|---|
| 英文别名 | Tox21_113765 | DB13573 | NSC52996 | NSC-52996 | Q4673059 | Purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo- | 2-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)aceticacid | 2-(1,3-Dimethyl-2,6-dioxo-2,3-dihydro-1H-purin-7(6H)-yl)a |
| 规格或纯度 | ≥98% |
| 英文名称 | Theophylline-7-acetic acid |
| 储存温度 | 充氩 |
| 运输条件 | 常规运输 |
| 纯度 | ≥98% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 488184352 |
|---|---|
| EC号 | 211-490-2 |
| 分子类型 | 小分子 |
| IIUPAC Name | 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic acid |
| INCHI | 1S/C9H10N4O4/c1-11-7-6(8(16)12(2)9(11)17)13(4-10-7)3-5(14)15/h4H,3H2,1-2H3,(H,14,15) |
| InChi Key | HCYFGRCYSCXKNQ-UHFFFAOYSA-N |
| Smiles | CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)O |
| Isomeric SMILES | CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)O |
| 关联CAS | 18833-13-1 |
| 分子量 | 238.2 |
| Beilstein号 | 279221 |
| Reaxy-Rn | 279221 |
| 密度 | 1.651 |
|---|---|
| 敏感性 | 对湿度敏感 |
| 熔点 | 270-272°C |
| 分子量 | 238.200 g/mol |
| XLogP3 | -0.800 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 5 |
| 可旋转键计数Rotatable Bond Count | 2 |
| 精确质量Exact Mass | 238.07 Da |
| 单同位素质量Monoisotopic Mass | 238.07 Da |
| 拓扑极表面积Topological Polar Surface Area | 95.700 Ų |
| 重原子数Heavy Atom Count | 17 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 385.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS07 |
|---|---|
| 信号词 | 警告 |
| 危险声明 |
H302: 吞食有害 H315: 引起皮肤刺激 H319: 引起严重眼睛刺激 H335: 可能引起呼吸道刺激 |
| 预防措施声明 |
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P271: 仅在室外或通风良好的地方使用。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P321: 特殊处理(请参阅此标签上的...)。 P330: 漱口 P302+P352: 如皮肤沾染:用水充分清洗。 P304+P340: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。 P405: 密闭存放 P403+P233: 存放在通风良好的地方。保持容器密闭。 P501: 将内容物/容器处理到。。。 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P301+P317: 如果被吞咽:请寻求医疗帮助。 P337+P317: 如果眼睛刺激持续:寻求医疗帮助。 P332+P317: 如果出现皮肤刺激:请寻求医疗帮助。 P319: 如果你感到不适,请寻求医疗帮助。 |
| WGK Germany | 2 |
| RTECS | UO7451300 |
| Merck Index | 24 |
| 个人防护装备 | dust mask type N95 (US),Eyeshields,Gloves |
| 1. G Dănilă,M Ungureanu,M Pavelescu,G Rusu,I Sandu. (1990-10-01) [The synthesis and anti-inflammatory properties of 7-theophyllineacetic acid derivatives].. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 94 ((3-4)): (581-586). [PMID:2131555] |
| 2. G Grosa,J S Franzone,G Biglino. (1986-03-01) Metabolism of doxophylline by rat liver microsomes.. Drug metabolism and disposition: the biological fate of chemicals, 14 ((2)): (267-270). [PMID:2870905] |
| 3. K Primbs. (1985-01-01) Therapeutic activity of ambroxol theophyllinacetate in chronic obstructive pulmonary diseases.. Clinical therapeutics, 7 ((6)): (733-736). [PMID:4075364] |
| 4. S Sved,I J McGilveray,N Beaudoin. (1981-04-01) The assay and absorption kinetics of oral theophylline-7-acetic acid in the human.. Biopharmaceutics & drug disposition, 2 ((2)): (177-184). [PMID:7248481] |
| 5. J G Ufkes,R S Leeuwin,M Ottenhof,A Zeegers,J Zuidema. (1981-10-01) Efficacy of theophylline and its N-7-substituted derivatives in experimentally induced bronchial asthma in the guinea-pig.. Archives internationales de pharmacodynamie et de therapie, 253 ((2)): (301-314). [PMID:7325766] |
| 6. Alaa El-Gindy,Samy Emara,Heba Shaaban. (2006-10-19) Development and validation of chemometrics-assisted spectrophotometric and liquid chromatographic methods for the simultaneous determination of two multicomponent mixtures containing bronchodilator drugs.. Journal of pharmaceutical and biomedical analysis, 43 ((3)): (973-982). [PMID:17046190] |
| 7. C Ferretti,G Coppi,M Blengio,E Genazzani. (1992-01-01) Inhibitory effect of theophylline, theophylline-7-acetic acid, ambroxol and ambroxol-theophylline-7-acetate on rat lung cAMP phosphodiesterase isoenzymes.. International journal of tissue reactions, 14 ((1)): (31-36). [PMID:1328102] |
| 8. M Eckstein,M Cegła. (1987-01-01) [Amides of 7-theophyllineacetic acid with antiarrhythmic action].. Acta poloniae pharmaceutica, 44 ((1)): (12-15). [PMID:3673625] |
| 9. J Zuidema,H Hilbers. (1980-06-13) Gas-liquid chromatographic determination of acephylline in urine.. Journal of chromatography, 182 ((3-4)): (445-447). [PMID:7391188] |
| 10. T Ooya,N Yui. (1999-04-01) Synthesis of theophylline-polyrotaxane conjugates and their drug release via supramolecular dissociation.. Journal of controlled release : official journal of the Controlled Release Society, 58 ((3)): (251-269). [PMID:10099151] |
| 11. Boika Tsvetkova,Jasmina Tencheva,Plamen Peikov. (2006-04-15) Esterification of 7-theophyllineacetic acid with diethylene glycol monomethyl ether.. Acta pharmaceutica (Zagreb, Croatia), 56 ((2)): (251-257). [PMID:16613730] |
| 12. Jiahui Ye, Longfei Mao, Luoyijun Xie, Rongjun Zhang, Yulin Liu, Lizeng Peng, Jianxue Yang, Qingjiao Li, Miaomiao Yuan. (2021) Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer. Frontiers in Pharmacology, 12 (753676). [PMID:34764872] [10.3389/fphar.2021.753676] |